EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Methodological issues in visible LED therapy dermatological research and reporting

David Robert Grimes iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0332995 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von David Robert Grimes. Beteiligte Einrichtung: TCD Biostatistics Unit, Discipline of Public Health and Primary Care, School of Medicine, Trinity College Dublin, Dublin, Ireland. Hauptthemen laut MEDLINE: Phototherapy, Dermatology, Skin Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The advent of mass-market Light Emitting Diodes (LEDs) has seen considerable interest in potential dermatological applications of LED light photobiomodulation (PBM) for a range of conditions, with a thriving market for direct-to-consumer LED treatments, including red light, blue light, and yellow light wavelengths. Evidence of efficacy is however mixed, and studies report a wide range of irradiances and wavelengths as well as outcome measures, rendering interpretation, comparison, and even efficacy evaluation prohibitive and impeding evidence synthesis.

Methods

This work establishes a model for comparing patient received doses, applying this to existent studies to ascertain potential inhomogeneity in reported doses and wavelengths employed. Patient doses were contrasted to equivalent solar exposure time needed to achieve fluences reported at specified wavelengths in the red light (RL), blue light (BL), and yellow light (YL) portion of the spectrum, yielding a comparison of reported doses to typical solar irradiance at the Earth’s surface. Methodological aspects including dose validation, blinding, and bias were also analysed.

Results

27 relevant studies for dermatological conditions including acne vulgaris ( n = 9 , 33.3%), wrinkle-reduction ( n = 5 , 18.5%), wound-healing ( n = 3 , 11.1%), psoriasis severity ( n = 3 , 11.1%), and erythemal index ( n = 7 , 25.9%) were assessed. Outcome measures were highly heterogeneous between studies, with total patients ranging from 14 – 105 (median: 26). Fluences and wavelengths used in treatment differed over three orders of magnitude across studies even for the same conditions ( 0 . 1 J c m − 2 − 1 2 6 J c m − 2 , median: 4 0 . 5 J c m − 2 ) . Derived equivalent solar time ranged from 0.01-19.35 hours (median: 3.3 hours), with central wavelengths between 405nm (BL) - 660nm (RL). No studies reported any dose validation, 10 (37.0%) were sponsored by the device manufacturer with a further 3 (11.1%) conducted by commercial dermatology practices offering the therapy under investigation. Assessors were unblinded to the treatment/ control groups in 33.3% ( n = 9 ), while a further 9 (33.3%) did not have any non-light control group, leaving only 33.3% ( n = 9 ) with both control group and blinded outcome assessment.

Conclusions

Results of this analysis suggest that fluences, wavelengths, and effective dose vary inconsistently between studies with often scant biological justification. This analysis suggests that better dose quantification and understanding of the underlying biophysics as well as plausible biological justifications for various wavelengths and fluences are imperative if LED therapy studies for dermatology are to be informative and research replicability improved.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhototherapyDermatologySkin DiseasesHumansLight

Autor:innen und Institutionen

  • TCD Biostatistics Unit, Discipline of Public Health and Primary Care, School of Medicine, Trinity College Dublin, Dublin, Ireland.
  • School of Physical Sciences, Dublin City University, Dublin, Ireland.

ORCID-Profile: David Robert Grimes

Förderung

  • Wellcome Trust

Zitieren

APA

Grimes, D. R. (2025). Methodological issues in visible LED therapy dermatological research and reporting. PLOS One. https://doi.org/10.1371/journal.pone.0332995

Vancouver

Grimes DR. Methodological issues in visible LED therapy dermatological research and reporting. PLOS One. 2025. doi:10.1371/journal.pone.0332995

BibTeX
@article{Grimes2025,
  author = {Grimes, David Robert},
  title = {Methodological issues in visible LED therapy dermatological research and reporting},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0332995}
}
Kostenlos starten →